Ambu A/S (FRA:547A)

Market Cap	2.89B -39.4%
Revenue (ttm)	814.76M +7.8%
Net Income	72.84M +66.9%
EPS	0.27 +67.9%
Shares Out	n/a
PE Ratio	39.68
Forward PE	30.87
Dividend	0.05 (0.51%)
Ex-Dividend Date	Dec 4, 2025

Volume	n/a
Average Volume	n/a
Open	10.72
Previous Close	10.71
Day's Range	10.72 - 10.72
52-Week Range	10.71 - 19.02
Beta	n/a
RSI	38.18
Earnings Date	Feb 4, 2026

About Ambu A/S

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also prov...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1937
• Employees: 5,200
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 547A

Financial Performance

In fiscal year 2025, Ambu A/S's revenue was 6.04 billion, an increase of 11.98% compared to the previous year's 5.39 billion. Earnings were 609.00 million, an increase of 159.15%.

Financial numbers in DKK